bioMérieux S.A. (EPA:BIM)

France · Delayed Price · Currency is EUR

74.10

+1.00 (1.37%)

Aug 20, 2026, 5:25 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Industrial Applications	638.90M	606.00M	575.30M	549.00M	492.60M
Clinical Applications	3.43B	3.37B	3.10B	3.04B	2.88B
Other	-	-	-	-	200.00K
Total	4.07B	3.98B	3.67B	3.59B	3.38B

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Corporate	1.00M	600.00K	900.00K	2.60M	2.80M
Asia-Pacific (ASPAC)	634.60M	656.20M	637.70M	624.30M	580.60M
Europe, The Middle East and Africa (EMEA) Excluding France	1.08B	1.03B	964.80M	-	901.60M
Americas (Excl. United States)	340.60M	324.10M	-	-	-
United States	1.78B	1.73B	-	-	-
France	235.60M	240.10M	225.50M	-	222.30M
Americas	-	-	1.85B	1.84B	1.67B
Europe, The Middle East and Africa (EMEA)	-	-	-	1.12B	-
Total	4.07B	3.98B	3.67B	3.59B	3.38B